Corbus Pharmaceuticals Holdings, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
ADVM
Adverum Biotechnologies, Inc. |
$4.79 | $152.56 M | -0.72 | 121 | $3.60 M |
AFMD
Affimed N.V. |
$1.36 | $93.50 M | -0.8 | 76 | $8.28 M |
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
ASMB
Assembly Biosciences, Inc. |
$17.35 | $78.73 M | -1.35 | 65 | $7.16 M |
BCAB
BioAtla, Inc. |
$0.60 | $73.14 M | -0.61 | 65 | $0 |
CTMX
CytomX Therapeutics, Inc. |
$1.14 | $127.79 M | 7.81 | 119 | $138.10 M |
CUE
Cue Biopharma, Inc. |
$1.75 | $71.99 M | -1.38 | 53 | $5.49 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
ELEV
Elevation Oncology, Inc. |
$0.84 | $192.87 M | -4.15 | 34 | $0 |
GLMD
Galmed Pharmaceuticals Ltd. |
$3.02 | $2.04 M | -0.21 | 3 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
KOD
Kodiak Sciences Inc. |
$9.32 | $151.83 M | -0.65 | 108 | $0 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
MREO
Mereo BioPharma Group plc |
$3.76 | $479.72 M | -22.8 | 33 | $10.00 M |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
NXTC
NextCure, Inc. |
$0.92 | $38.88 M | -0.61 | 82 | $0 |
OCEA
Ocean Biomedical, Inc. |
$0.69 | $50.07 M | -0.48 | 9 | $0 |
SPRO
Spero Therapeutics, Inc. |
$1.08 | $75.85 M | 3.19 | 46 | $96.74 M |
TRVI
Trevi Therapeutics, Inc. |
$4.32 | $171.86 M | -7.18 | 27 | $0 |
VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 143 | $0 |
ZURA
Zura Bio Limited |
$2.50 | $255.37 M | 6.17 | 14 | $0 |
ZVSA
ZyVersa Therapeutics, Inc. |
$1.25 | $3.68 M | 0 | 7 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
